Progesterone Metabolites as Farnesoid X Receptor Inhibitors

Publisher： Karger

E-ISSN： 1421-9875|33|3|300-306

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.3, 2015-05, pp. : 300-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesoid X Receptor an Emerging Target to Combat Obesity

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 185-190

Karger

Access to resources Recommend Favorite

The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism

By Kuipers Folkert   Claudel Thierry   Sturm Ekkehard   Staels Bart  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 4, 2004-12 ,pp. : 319-326

Springer Publishing Company

Access to resources Recommend Favorite

Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 426-432

Karger

Access to resources Recommend Favorite

Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 178-184

Karger

Access to resources Recommend Favorite

Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 241-245

Karger

Access to resources Recommend Favorite